top of page

Pharmaceutical Benefit Plan Settlements

  • Writer: MCAG
    MCAG
  • Jul 8, 2024
  • 2 min read

Updated: May 28

$198.4 Million available via Pharmaceutical Benefit Plan Settlements

Overview

There are typically several active lawsuits and/or class action settlements that fall into the category of “pharmaceutical benefit plan settlements.” Under these cases, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or stabilized prices.


The prices were allegedly manipulated as a result of anti-competitive practices undertaken by the drug manufacturers. The number of these opportunities in any given year varies, but there can be several available at the same time.


Immediately Available Settlement(s):

 

Xyrem (Sodium Oxybate) Settlement


Date Range: January 2015 - May 2025


Settlement Fund: $198.4 million


Filing Deadline: 10/3/2025


Settlement Overview: This settlement resolves claims that drugmakers illegally blocked generic Xyrem-a drug used to treat narcolepsy-from entering the market, keeping prices high and forcing buyers to overpay.


Eligible Locations: To be a member of the Settlement Class, you must have paid, and/or provided reimbursement for some or all of the purchase price for Xyrem (brand or generic) or Xywav in the United States and its territories, for consumption by your members, employees, insureds, participants, or beneficiaries, and other than for resale, from January 1, 2017, through May 16, 2025.


Class States: Alaska, Arizona, Arkansas, California, Connecticut, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, West Virginia, Wisconsin.

 

Eligible Drugs: Xyrem (brand or generic) and Xywav


Recommended Next Steps Data is often required to complete your claim for settlements in this category. Connect us with a member of your Benefits Department so an MCAG representative can describe the information that is necessary to complete your claim for these pharmaceutical settlements. We typically only need a 5 to 10 minute call. We will quickly review the process so we can efficiently obtain necessary information from your Pharmacy Benefit Manager (i.e. CVS Caremark, Express Scripts, OptumRX) to pursue current and future pharmaceutical settlements.


Eligible contracted clients can expect to be contacted by an MCAG representative to review and assist with gathering the necessary information for these settlements.


MCAG is not the Settlement/Class Administrator, and this is not an official settlement website.


Need more information? CLICK HERE to complete our contact form and an MCAG representative will respond shortly.


Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.

Managed Care Advisory Group

7150 Granite Circle 
Toledo, Ohio 43617

info@mcaginc.com

MCAG is a revenue recovery consulting firm where teams of advisers, researchers, and IT professionals provide ongoing expertise, analysis, and technology to ensure our clients capture every recoverable dollar.  

Payment Card Settlement Disclaimer: The claims filing deadline of February 4, 2025 has passed. No-cost assistance is available from the Class Administrator and Class Counsel. No one is required to sign up with any third-party service in order to participate in any monetary relief. For additional information regarding the status of the litigation, interested persons may visit  http://www.paymentcardsettlement.com, the Court-approved website for this case.

© 2025 MCAG, LLC   |   Security Notice   |    Privacy Notice

pci-dss.png
bottom of page